Ads
related to: t-cell therapy- How This Treatment Works
Get Info On Lymphoma
Treatment & See How It Works
- Safety & Side Effects
Read Important Safety And Possible
Side Effects Information.
- Treatment Centers
Find A Treatment Center Near You
FDA-Approved Treatment Option
- Take The Quiz
Find Out If This Treatment Option
Is Right For You
- Real Patient Stories
Hear How Cell Therapy Could Help
From Real Patients And Caregivers
- Clinical Trial Results
Find Info On Clinical Trials
For This Treatment Option.
- How This Treatment Works
Search results
Amit Kumar Purchases 25,000 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) Stock
ETF DAILY NEWS· 10 hours agoAnixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) CEO Amit Kumar bought 25,000 shares of the firm’s stock in a transaction that occurred on Friday, June 7th. The stock was acquired at ...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 5 days ago“The new data being presented from our vast clinical development programme are an incredible...
PRGN-2012 shows promise in recurrent respiratory papillomatosis study By Investing.com
Investing.com· 6 days agoPrecigen, Inc. (NASDAQ:PGEN), a biopharmaceutical company, announced today positive results from a...
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
Tehachapi News· 6 days agoPoseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients ...
Halsey reveals she has lupus and a rare blood-cell disorder. Here's what to know.
Yahoo Life· 3 days agoBut in the meantime, there is a “limited treatment arsenal,” she says. What is Halsey’s rare...
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for...
Morningstar· 4 days agoABBV-383 is a B-cell maturation antigen (BCMA) bispecific antibody T-cell engager being evaluated in relapsed/refractory multiple myeloma (r/r MM)The CERVINO ...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 3 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoWARREN, N.J., June 07, 2024 (GLOBE NEWSWIRE) -- A release was issued under a similar headline on Thursday, June 6th by Tevogen Bio Holdings Inc. (Nasdaq: TVGN). Please note that the second paragraph has been corrected and a photo is now included
Sorrento Therapeutics (NASDAQ:SRNE) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 10 hours agoStockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’ ...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
Ads
related to: t-cell therapy